| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
16,633 |
13,273 |
$1.24M |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
11,970 |
9,417 |
$571K |
| 99396 |
Periodic comprehensive preventive medicine reevaluation, established patient, 40-64 years |
2,252 |
2,060 |
$189K |
| 99395 |
Periodic comprehensive preventive medicine reevaluation, established patient, 18-39 years |
1,315 |
1,232 |
$109K |
| 87811 |
Infectious agent antigen detection by immunoassay; SARS-CoV-2 (COVID-19) |
1,793 |
1,627 |
$73K |
| 99211 |
Office or other outpatient visit for the evaluation and management of an established patient, minimal severity |
3,792 |
3,377 |
$47K |
| 99394 |
Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) |
494 |
436 |
$41K |
| 96127 |
|
2,719 |
2,378 |
$39K |
| 96160 |
|
2,539 |
2,409 |
$37K |
| U0002 |
2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc |
604 |
528 |
$31K |
| 99212 |
Office or other outpatient visit for the evaluation and management of an established patient, straightforward |
1,162 |
1,055 |
$29K |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
1,475 |
517 |
$29K |
| G2023 |
Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source |
971 |
890 |
$22K |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
1,380 |
1,089 |
$22K |
| 76140 |
|
1,090 |
916 |
$21K |
| 92551 |
|
1,299 |
1,150 |
$20K |
| 87426 |
Infectious agent antigen detection, SARS-CoV-2 (COVID-19) |
552 |
502 |
$19K |
| 99385 |
|
112 |
104 |
$12K |
| 99393 |
Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) |
153 |
132 |
$11K |
| 99173 |
|
1,285 |
1,150 |
$9K |
| 90686 |
|
450 |
352 |
$8K |
| 0012A |
|
120 |
120 |
$5K |
| 0011A |
|
137 |
137 |
$3K |
| 90756 |
|
159 |
142 |
$3K |
| 99401 |
|
96 |
62 |
$3K |
| 0013A |
|
67 |
66 |
$3K |
| 96110 |
Developmental screening, with scoring and documentation, per standardized instrument |
162 |
161 |
$3K |
| 99386 |
|
15 |
15 |
$2K |
| 90734 |
|
163 |
115 |
$2K |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
29 |
24 |
$1K |
| 90688 |
|
84 |
68 |
$1K |
| 99397 |
|
12 |
12 |
$941.50 |
| 99423 |
|
17 |
15 |
$740.55 |
| 99406 |
|
53 |
38 |
$230.08 |
| 85014 |
|
92 |
70 |
$213.44 |
| 85018 |
|
92 |
70 |
$213.44 |